
Advance Market Analytics published a new research publication on "Dyslexia Treatment Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Dyslexia Treatment market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in the study are Teva Pharmaceutical Industries Ltd (Israel), Eli Lilly & Company (United States), Novartis AG (United Kingdom), Purdue Pharma (United States), Pfizer Inc. (United States), Jubilant Cadista (United States), Micro Labs (India), Srikem Labs (India), Gangwal Chemicals Pvt. Ltd (India), RPG Life Sciences Ltd (India), Wallace Pharmaceuticals Ltd (United States), Cian Healthcare Pvt Ltd (India), GlaxoSmithKline (United Kingdom).